Studies on the Toxicity of Streptomycin for Man: A Preliminary Report

Science (New York, N.Y.)
|March 22, 1946
PubMed

Insights

Streptomycin administration showed no serious toxicity to the kidneys or liver in limited trials. Observed reactions were likely caused by impurities in the streptomycin drug preparations.

Area of Science:

  • Pharmacology
  • Toxicology
  • Internal Medicine

Background:

  • Parenteral streptomycin administration requires careful monitoring for potential adverse effects.
  • Understanding the safety profile of streptomycin is crucial for clinical application.

Purpose of the Study:

  • To evaluate the safety and toxicity of parenteral streptomycin.
  • To identify potential adverse reactions associated with streptomycin use.

Main Methods:

  • Parenteral administration of streptomycin.
  • Monitoring of renal and hepatic function.
  • Blood studies conducted pre- and post-administration.
  • Observation and documentation of patient reactions.

Main Results:

  • No evidence of serious renal or hepatic toxicity was found.
  • Observed reactions included fever, arthralgias, and skin rashes.
  • Histamine-like effects were also noted.

Conclusions:

  • Streptomycin appears to have a favorable safety profile regarding major organ toxicity in this study.
  • Adverse reactions are likely attributable to impurities in the streptomycin preparations rather than the drug itself.
  • Further investigation into streptomycin purity is warranted to minimize side effects.

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...